Scott Isaacs (@scottisaacsmd) 's Twitter Profile
Scott Isaacs

@scottisaacsmd

President-Elect @theaace, endocrinologist, obesity medicine, #MASLD, Emory Med School adjunct faculty. Posts are my own.

ID: 213754594

linkhttp://www.atlantaendocrine.com calendar_today09-11-2010 18:24:54

5,5K Tweet

13,13K Takipçi

2,2K Takip Edilen

Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

This meta-analysis of 12 RCTs found that the effects of SGLT2 inhibitors on cardiovascular and kidney outcomes are consistent regardless of background use of GLP-1 RAs. thelancet.com/journals/landi…

This meta-analysis of 12 RCTs found that the effects of SGLT2 inhibitors on cardiovascular and kidney outcomes are consistent regardless of background use of GLP-1 RAs.
thelancet.com/journals/landi…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Systematic review and meta-analysis on the effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes. Intermittent fasting was more effective than calorie restriction for weight loss but not for reducing fat mass,

Systematic review and meta-analysis on the effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes. Intermittent fasting was more effective than calorie restriction for weight loss but not for reducing fat mass,
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Patients with type 2 diabetes have higher liver stiffness and fat fraction compared with those with type 1 diabetes. Even after adjusting for sex, BMI, and diabetes duration, liver stiffness was 5 times higher in patients with T2D. …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

Patients with type 2 diabetes have higher liver stiffness and fat fraction compared with those with type 1 diabetes. Even after adjusting for sex, BMI, and diabetes duration, liver stiffness was 5 times higher in patients with T2D.
…ubs.pericles-prod.literatumonline.com/doi/10.1111/do…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

People with PCOS have a higher risk of type 2 diabetes, hypertension, hepatocellular carcinoma, and depression or anxiety compared with controls. They also have a higher risk for cardiovascular disease, hepatic steatosis, and hepatic fibro-inflammation. academic.oup.com/jcem/advance-a…

People with PCOS have a higher risk of type 2 diabetes, hypertension, hepatocellular carcinoma, and depression or anxiety compared with controls. They also have a higher risk for cardiovascular disease, hepatic steatosis, and hepatic fibro-inflammation.
academic.oup.com/jcem/advance-a…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

This study compared medication adherence to SGLT2 inhibitors and GLP-1 receptor agonists through a meta-analysis. In all studies, no difference in nonadherence was found between the two medications. However, in studies conducted in the US, SGLT2 inhibitor use was associated with

This study compared medication adherence to SGLT2 inhibitors and GLP-1 receptor agonists through a meta-analysis. In all studies, no difference in nonadherence was found between the two medications. However, in studies conducted in the US, SGLT2 inhibitor use was associated with
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

Strength and endurance training can be effective in reducing visceral fat volume and body weight. …ubs.pericles-prod.literatumonline.com/doi/10.1111/do…

Strength and endurance training can be effective in reducing visceral fat volume and body weight.
…ubs.pericles-prod.literatumonline.com/doi/10.1111/do…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

This study evaluated the efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors, in liver transplant recipients with diabetes. The results showed improvements in weight/BMI and A1c levels for both medication groups. …ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…

This study evaluated the efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors, in liver transplant recipients with diabetes. The results showed improvements in weight/BMI and A1c levels for both medication groups.
…ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

This is a nice review of the role of incretin receptor agonists in the treatment of obesity. …ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…

This is a nice review of the role of incretin receptor agonists in the treatment of obesity.
…ubs.pericles-prod.literatumonline.com/doi/epdf/10.11…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

The metabolically healthy obesity phenotype is a dynamic status over time and can convert to metabolically unhealthy increasing the risk of colorectal cancer. onlinelibrary.wiley.com/doi/abs/10.100…

The metabolically healthy obesity phenotype is a dynamic status over time and can convert to metabolically unhealthy increasing the risk of colorectal cancer.
onlinelibrary.wiley.com/doi/abs/10.100…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

We must address the #MASLD awareness gap, improve educational quality and prepare for the digitally quantified self. Jeffrey V. Lazarus onlinelibrary.wiley.com/doi/epdf/10.11…

Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

In the liver-heart-kidney-metabolic axis, the common pathophysiological basis of #MASLD, cardiovascular disease, chronic kidney disease, and type 2 diabetes is the same. #CVD #CKD #diabetes #MASH pubmed.ncbi.nlm.nih.gov/38565488/

In the liver-heart-kidney-metabolic axis, the common pathophysiological basis of #MASLD, cardiovascular disease, chronic kidney disease, and type 2 diabetes is the same. #CVD #CKD #diabetes #MASH
pubmed.ncbi.nlm.nih.gov/38565488/